Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Magdalena Kaneva

Senior Postdoctoral Research Fellow

Dr Kaneva graduated from Jacobs University Bremen, Germany in 2007 with a BSc in Biochemistry and Cell Biology. Same year, she was awarded a PhD studentship from the University of Westminster, where she investigated the role inflammation and traumatic injury play in the initiation and perpetuation of cartilage destruction. She discovered that melanocortin peptides support cartilage health by promoting the activation of pro-resolving and pro-anabolic circuits within chondrocytes.

In 2011, Dr Kaneva joined the William Harvey Research Institute to conduct a discovery science project aimed at identifying and validating novel pro-resolving and cartilage-reparative molecules, under the mentorship of Prof Mauro Perretti. Later, Dr Kaneva was awarded a UCB-WHRL grant to target Fetuin-A as an innovative chondroprotective strategy.

In 2018, Dr Kaneva joined the team of Prof Francesco Dell’Accio where she produced a recombinant Agrin molecule and contributed towards elucidating its receptor repertoire and the downstream MoA responsible for its chondrogenic properties.

Research Interests

Dr Kaneva’s research focus is on harnessing the properties of endogenous pro-resolving molecules and the definition of their biology and cartilage reparative signatures to inform innovative therapeutic approaches for the treatment of osteoarthritis and joint pathologies.


ORCID: 0000-0003-3822-749X

Twitter: @TheReGenLab